000424
1997, 277, 301-306. 137. Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study / C.F. Green [et al.] // J. Clin. Pharm. Ther., 2000, 25 (5), 355-361. 138. Adverse Drug Reactions: Can consumers provide early warning? / A. Mitchell [et al.] // Pharmacoepidemiol. Drug Safe, 1994, 3, 257-264. 139. Adverse Event Reporting System (FDA, CDER, MedWatch program, , Office of Post-Marketing Drug Risk Assessment, National Cooidonating Counsil for Safe Medication Practices)/ Phillips J. [et al.]. - JAMA, 1998, 279 ,1200—5. 140. Anbar, M. Quantitative Dynamic Telethermometry in Medical Diagnosis and Management /M.Anbar Boca Raton: CRC Press, 1994. - Ch. 4, p. 99. 141. Anbar, M. Thermology and facial telethermography. Part I: History and technical review / M. Anbar, ВЖ. Gratt, D. Hong // Dentomaxillofac Radiology. - 1998, №. 2 - P. 61. 142. Benumof, J.L. Clinical procedures in anesthesia and intensive care / J.L. Benumof. - Philadelphia: Lippincott, 1992. - 600 p. 143. Blackshear R.H., Crosson K.C. Reduction in Pulmonary Embolism after Total Joint Arthroplasty: Three Years of Experience with Extended-Release Epidural Morphine / R.H. Blackshear, K.C. Crosson // Pain Pract, 2010. - May/June. - Vol. 10, Issue 3, p. 235-244. 144. Causal or casuas? The role of causality assessment in pharmacovigilance / R. Meyboom [et al.] // Drug safety, Reprint collection, 2001, 374-389. 145. Clinical Eye and Vision Care. Issue 4. Vol. 7. December 1995. P.237-240. 146. Davies, H. Что такое мета-анализ? / H. Davies, I. Crombie // Клин. фармакол. и терапия, 1999, 8 (6), 52-56. - 193 - 193
RkJQdWJsaXNoZXIy MzI5Njcy